ESR/ERS statement paper on lung cancer screening

H. Kauczor, A. Baird, T. Blumet al.

Source: Guideline 2020
Number: 2020

Full text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Kauczor, A. Baird, T. Blumet al.. ESR/ERS statement paper on lung cancer screening. Guideline 2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
ESR/ERS white paper on lung cancer screening
Source: Eur Respir J 2015; 46: 28-39
Year: 2015



Introduction on the ESR/ERS statement on low-dose lung cancer screening
Source: International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?
Year: 2019


ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe
Source: International Congress 2018 – State of the art session: Thoracic oncology
Year: 2018


ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe
Source: Eur Respir J, 52 (6) 1800610; 10.1183/13993003.00610-2018
Year: 2018



ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe
Source: Guideline 2018
Year: 2018

The ALA/ATS implementation guide on lung cancer screening
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018


Lung cancer screening: the critical review
Source: International Congress 2015 – Lung cancer screening: how to implement a comprehensive preventive approach
Year: 2015



A study of the public‘s awareness of the causation of lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 184s
Year: 2005

An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006

A study of design an original questionnaire for evaluating risks of lung cancer
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011

Emphysema, COPD and lung cancer screening. Update of an ongoing study
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012


Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Molecular test supporting early lung cancer detection project based on pilot Pomeranian lung cancer screening program
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011

Evolution in the pathological study of lung cancer
Source: Virtual Congress 2020 – Management issues in thoracic oncology
Year: 2020


Re-audit of adherence to NICE guidelines on investigation of lung cancer
Source: Annual Congress 2007 - Diagnosis of thoracic malignancies
Year: 2007


Evolution in the diagnostic approach to lung cancer
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021


Patient perspectives and experience on the diagnostic pathway of lung cancer – a qualitative study
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018

Lung cancer screening white paper: a slippery step forward?
Source: Eur Respir J 2015; 46: 1519-1520
Year: 2015


Lung cancer screening white paper: a slippery step forward?
Source: Eur Respir J 2015; 46: 1521-1522
Year: 2015